Protocol NP27946: Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Ritonavir-Boosted DANOPREVIR in Combination with Peginterferon Alfa-2a Plus Ribavirin in Treatment-Naive Patients and with addition of RO5024048 in Previ